Cas:1353991-01-1 ((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride manufacturer & supplier

Chemical Name:((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride

CAS.NO:1353991-01-1

Synonyms:((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride

Molecular Formula:C₁₆H₂₅ClN₂

Molecular Weight:280.8361

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride Use and application,((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride technical grade,usp/ep/jp grade.

Related News: Importance of evaluating biocatalytic processes during development N-(2-methoxy-2-(4-methoxyphenyl)ethyl)-N-methylnitrous amide manufacturers The Japanese drugmaker is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines, Pacific Coast Business Times first reported. Takeda was joined by the city’s mayor, Claudia Bill-de la Peña, for a groundbreaking event on Thursday, July 22. {4-[ethyl-(2-phenylcarbamoyloxy-ethyl)-amino]-2-methyl-benzylidene}-malononitrile suppliers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 1-chloro-4-(2-methyl-4-nitrophenoxy)-2-(propylsulfonyl)benzene vendor & factory.